Status:
COMPLETED
Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Sepsis
Septic Shock
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The mortality induced by infections in onco-hematological patients is abnormally high at the acute phase of septic shock. Consequently, it is important to detect the population with a high risk of sho...
Detailed Description
Method: Monocentric prospective study with diagnostic and prognostic expectations. Primary objective: Identification and characterization of early proteic biomarkers predictive of short term mortali...
Eligibility Criteria
Inclusion
- Patient from oncology or hematology with a septic shock
- Patient aged 18 years and older
- Inclusion within the 24 hours of the septic shock in the intensive care unit
- Signed consent according to the emergency reglementation
Exclusion
- Pregnancy, breast feeding
- Patient with decision of care limitation
- Patient with legal protection
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00930085
Start Date
August 1 2008
End Date
May 1 2011
Last Update
September 14 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Paoli-Calmettes
Marseille, France